Pasar al contenido principal

PAPEL DE LA MITOFAGIA EN LA INTERACCION RETINA EPITELIO PIGMENTARIO

PID2021-126864NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aging STINGs: mitophagy at the crossroads of neuroinflammation

  • Jiménez-Loygorri, Juan Ignacio
  • Boya, Patricia
Loss of proteostasis and dysregulated mitochondrial function are part of the traditional hallmarks of aging, and in their last revision impaired macroautophagy and chronic inflammation are also included. Mitophagy is at the intersection of all these processes but whether it undergoes age-associated perturbations was not known. In our recent work, we performed a systematic and systemic analysis of mitolysosome levels in mice and found that, despite the already-known decrease in nonselective macroautophagy, mitophagy remains stable or increases upon aging in all tissues analyzed and is mediated by the PINK1-PRKN-dependent pathway. Further analyses revealed a concomitant increase in mtDNA leakage into the cytosol and activation of the CGAS-STING1 inflammation axis. Notably, both phenomena are also observed in primary fibroblasts from aged human donors. We hypothesized that mitophagy might be selectively upregulated during aging to improve mitochondrial fitness and reduce mtDNA-induced inflammation. Treatment with the mitophagy inducer urolithin A alleviates age-associated neurological decline, including improved synaptic connectivity, cognitive memory and visual function. Supporting our initial hypothesis, urolithin A reduces the levels of cytosolic mtDNA, CGAS-STING1 activation and neuroinflammation. Finally, using an in vitro model of mitochondrial membrane permeabilization we validated that PINK1-PRKN-mediated mitophagy is essential to resolve cytosolic mtDNA-triggered inflammation. These findings open up an integrative approach to tackle aging and increase healthspan via mitophagy induction., Research in the P.B. lab is supported by grants 310030_215271 Swiss National Science Foundation (SNSF) and PID2021-126864NB I00 from MCIN, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fast and quantitative mitophagy assessment by flow cytometry using the mito-QC reporter

  • Jiménez-Loygorri, Juan Ignacio
  • Jiménez-García, Carlos
  • Viedma-Poyatos, Álvaro
  • Boya, Patricia
10 p.-4 fig., Mitochondrial quality control is finely tuned by mitophagy, the selective degradation of mitochondria through autophagy, and mitochondrial biogenesis. Removal of damaged mitochondria is essential to preserve cellular bioenergetics and prevent detrimental events such as sustained mitoROS production, pro-apoptotic cytochrome c release or mtDNA leakage. The array of tools available to study mitophagy is very limited but in constant development. Almost a decade ago, we developed a method to assess mitophagy flux using MitoTracker Deep Red in combination with lysosomal inhibitors. Now, using the novel tandem-fluorescence reporter mito-QC (mCherry-GFP-FIS1101−152) that allows to differentiate between healthy mitochondria (mCherry+GFP+) and mitolysosomes (mCherry+GFP−), we have developed a robust and quantitative method to assess mitophagy by flow cytometry. This approach has been validated in ARPE-19 cells using PINK1/Parkin-dependent (CCCP) and PINK1/Parkin-independent (DFP) positive controls and complementary techniques. Furthermore, we show that the mito-QC reporter can be multiplexed, especially if using spectral flow cytometry, to simultaneously study other cellular parameters such as viability or ROS production. Using this technique, we evaluated and characterized two prospective mitophagy inducers and further dissected their mechanism of action. Finally, using mito-QC reporter mice, we developed a protocol to measure mitophagy levels in the retina ex vivo. This novel methodology will propel mitophagy research forward and accelerate the discovery of novel mitophagy modulators. Copyright © 2024 Jiménez-Loygorri, Jiménez-García, Viedma-Poyatos and Boya., Research in the PB lab is supported by grants 310030_215271 Swiss National Science Foundation (SNSF) and PID2021-126864NB I00 from MCIN, Spain. JJ-L holds a FPI fellowship from MCIN (PRE2019-088222). CJ-G is supported by the University of Fribourg., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urolithin A promotes p62-dependent lysophagy to prevent acute retinal neurodegeneration

  • Jiménez-Loygorri, Juan Ignacio
  • Viedma-Poyatos, Álvaro
  • Gómez-Sintes, Raquel
  • Boya, Patricia
17 p.-6 fig.-1 graph. abst., Background: Age-related macular degeneration (AMD) is the leading cause of blindness in elderly people in the developed world, and the number of people affected is expected to almost double by 2040. The retina presents one of the highest metabolic demands in our bodies that is partially or fully fulfilled by mitochondria in the neuroretina and retinal pigment epithelium (RPE), respectively. Together with its post-mitotic status and constant photooxidative damage from incoming light, the retina requires a tightly-regulated housekeeping system that involves autophagy. The natural polyphenol Urolithin A (UA) has shown neuroprotective benefits in several models of aging and age-associated disorders, mostly attributed to its ability to induce mitophagy and mitochondrial biogenesis. Sodium iodate (SI) administration recapitulates the late stages of AMD, including geographic atrophy and photoreceptor cell death., Methods: A combination of in vitro, ex vivo and in vivo models were used to test the neuroprotective potential of UA in the SI model. Functional assays (OCT, ERGs), cellular analysis (flow cytometry, qPCR) and fine confocal microscopy (immunohistochemistry, tandem selective autophagy reporters) helped address this question., Results: UA alleviated neurodegeneration and preserved visual function in SI-treated mice. Simultaneously, we observed severe proteostasis defects upon SI damage induction, including autophagosome accumulation, that were resolved in animals that received UA. Treatment with UA restored autophagic flux and triggered PINK1/Parkin-dependent mitophagy, as previously reported in the literature. Autophagy blockage caused by SI was caused by severe lysosomal membrane permeabilization. While UA did not induce lysosomal biogenesis, it did restore upcycling of permeabilized lysosomes through lysophagy. Knockdown of the lysophagy adaptor SQSTM1/p62 abrogated viability rescue by UA in SI-treated cells, exacerbated lysosomal defects and inhibited lysophagy., Conclusions: Collectively, these data highlight a novel putative application of UA in the treatment of AMD whereby it bypasses lysosomal defects by promoting p62-dependent lysophagy to sustain proteostasis., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Research in the P.B. lab is supported by grants 310030_215271 Swiss National Science Foundation (SNSF) and PID2021-126864NB I00 from MCIN, Spain. J.I.J-L. holds a FPI fellowship from MCIN (PRE2019-088222)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex-specific and cell-type-specific changes in chaperone-mediated autophagy across tissues during aging

  • Khawaja, Rabia R.
  • Martín-Segura, Adrián
  • Santiago-Fernández, Olaya
  • Sereda, Rebecca
  • Lindenau, Kristen
  • McCabe, Mericka
  • Macho-Gonzalez, Adrián
  • Jafari, Maryam
  • Scrivo, Aurora
  • Gómez-Sintes, Raquel
  • Chavda, Bhakti
  • Saez-Ibanez, Ana Rosa
  • Tasset, Inmaculada
  • Arias, Esperanza
  • Xie, Xianhong
  • Kim, Mimi
  • Kaushik, Susmita
  • Cuervo, Ana Maria
39 pag.-7 fig.-10 ext.dat.fig., Aging leads to progressive decline in organ and tissue integrity and function, partly due to loss of proteostasis and autophagy malfunctioning. A decrease with age in chaperone-mediated autophagy (CMA), a selective type of lysosomal degradation, has been reported in various organs and cells from rodents and humans. Disruption of CMA recapitulates features of aging, whereas activating CMA in mice protects against age-related diseases such as Alzheimer’s, retinal degeneration and/or atherosclerosis. However, sex-specific and cell-type-specific differences in CMA with aging remain unexplored. Here, using CMA reporter mice and single-cell transcriptomic data, we report that most organs and cell types show CMA decline with age, with males exhibiting a greater decline with aging. Reduced CMA is often associated with fewer lysosomes competent for CMA. Transcriptional downregulation of CMA genes may further contribute to CMA decline, especially in males. These findings suggest that CMA differences may influence organ vulnerability to age-related degeneration., This work was supported by grants from the National Institutes of Health (NIH) (AG021904, AG054108 and DK098408 (to A.M.C.) and AG031782 (to A.M.C. and M.K.)), the generous support of the Hevolution Foundation, JPB Foundation, the Rainwaters Foundation,Robert and Renee Belfer (to A.M.C.) and the Grace Science Foundation (to S.K.). R.R.K. was supported by an IRACDA-BETTR grant and NIH T32AGAG023475, A.M.-S. by a Ramon Areces Postdoctoral Fellowship, A.M.-G. by a Margarita Salas contract for young PhD training, R.G.-S. by PID2021-126864NB I00 from MCIN (Spain), E.A. by NIH DK124308, M.M. by NIH T32AG023475, M.J. by NIH T32HL14445 and R.S. by NIH T32GM007491 and NIH F31 AG084192, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos

  • Villarejo-Zori, Beatriz
  • Zapata-Muñoz, Juan
  • Sierra-Filardi, Elena
  • Ramírez-Pardo, Ignacio
  • Montava-Garriga, Lambert
  • Ganley, Ian G.
  • Boya, Patricia
13 p.-6 fig., Photoreceptor degeneration is the hallmark of retinitis pigmentosa. Identifying general mechanisms underlying photoreceptor cell death is key to developing effective, mutation-independent treatments to prevent vision loss. Mitophagy is a protective pathway that prevents age-dependent vision loss and is upregulated by iron chelators such as deferiprone (DFP). Therefore, we aimed to investigate the ability of DFP to protect against retinal degeneration via mitophagy. First, we treated mitophagy reporter mice with MNU, a classic inducer of photoreceptor degeneration. MNU induced retinal degeneration and comprehensively inhibited mitophagy, while also inducing lysosomal basification and lysosomal membrane permeabilization. Although DFP rescued cells and retinal explants from the toxic effects of MNU, this effect was independent of mitophagy. Further investigation revealed that PAR polymers accumulation associated with parthanatos cell death was reduced to similar extents by DFP and the PARP inhibitor olaparib. In conclusion, iron chelation can protect against MNU-induced photoreceptor degeneration in retinal explants via parthanatos inhibition., Research in the PB lab is supported by grants 310030_215271 from the Swiss National Science Foundation (SNSF), PID2021-126864NB I00 from MCIN, and the PTI+ Neuroaging from CSIC; Spain. JZM holds a FPU fellowship from MCIN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The developing retina undergoes mitochondrial remodeling via PINK1/PRKN-dependent mitophagy

  • Zapata-Muñoz, Juan
  • Jiménez-Loygorri, Juan Ignacio
  • Stumpe, Michael
  • Villarejo-Zori, Beatriz
  • Alonso-Gil, Sandra
  • Teresak, Petra
  • Mathai, Benan J.
  • Ganley, Ian G.
  • Simonsen, Anne
  • Dengjel, Jörn
  • Boya, Patricia
15 p.-6 fig., Mitophagy, the selective degradation of mitochondria, is essential for retinal ganglion cell (RGC) differentiation and retinal homeostasis. However, the specific mitophagy pathways involved and their temporal dynamics during retinal development and maturation remain poorly understood. Using proteomics analysis of isolated mouse retinas across developmental stages and the mitophagy reporter mouse line, mito-QC, we characterized mitophagy throughout retinogenesis. While mitolysosomes were more prevalent in the mature retina, we observed two distinct mitophagy peaks during embryonic development. The first, independent of PTEN-induced kinase 1 (PINK1) activation, was associated with RGCs. The second, PINK1-dependent peak was triggered after an increase in retinal oxidative stress. This PINK1-dependent, oxidative stress-induced mitophagy pathway is conserved in mice and zebrafish, providing the first evidence of programmed, PINK1-dependent mitophagy during development., Research in the P.B. and J.D. labs are supported by grants 310030_215271 and 310030_212187 respectively, from the Swiss National Science Foundation (SNSF), and PID2021-126864NB I00 from MCIN, Spain. JZM holds a FPU fellowship from MCIN. J.I.J-L. is supported by a FPI fellowship from MCIN (PRE2019-088222) and a CNIO Friends postdoctoral fellowship. BVZ is supported by PTI+ Neuroaging from the CSIC, Spain and P.T. by the Marie Skłodowska-Curie ETN grant under the European Union’s Horizon 2020 Research and Innovation Programme (765912 DRIVE). A.S. and B.J.M are funded by the Research Council of Norway through its Centres of Excellence funding scheme (262652) and the Norwegian Cancer Society (project number 223278)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis

  • Cao, Shu-Qin
  • Jiménez-Loygorri, Juan Ignacio
  • Qiu, Yunguang
  • Kang, You Jung
  • Do, Khanh Van
  • Smith, Annabel E.
  • Huang, Junjie
  • Pan, Jun-ping
  • Mao, Lipeng
  • Li, Ang
  • Yang, Hangge
  • Aman, Yahyah
  • Lagartos, Maria Jose Donate
  • Lautrup, Sofie Hindkjær
  • Chen, Anbin
  • Liang, Kristina Xiao
  • Zhang, Hailong
  • Yi, Juan
  • Jin, Xurui
  • Cheung, Tin Cho
  • Apokotou, Olympia
  • Papastefanaki, Florentia
  • Matsas, Rebecca
  • McEwan, William A
  • Cheng, Feixiong
  • Cho, Hansang
  • Chen, Guobing
  • Su, Huanxing
  • Palikaras, Konstantinos
  • Luo, Oscar Junhong
  • Zhao, Qian Hua
  • Ding, Ding
  • van Duijn, Cornelia
  • Tavernarakis, Nektarios
  • Boya, Patricia
  • Tencomnao, Tewin
  • Fang, Evandro F
High consumption of colorful fruits and vegetables correlates with low dementia risk, but the exact molecules and the underlying biological mechanisms governing their bioactive profiles are largely unknown. Using a 10-year observational cohort study coupled with an AI-driven systems pharmacology platform, we identified a natural triterpenoid compound found in colorful fruits and vegetables, α-Amyrin (αA), as a therapeutic candidate for Alzheimer's disease (AD). The efficacy of αA in treating the symptoms of AD, such as Tau tangles, damaged mitochondria, and memory loss, was examined using cross-species models; αA retained memory in AD-like animal models while also strongly inhibiting Tau pathology, especially p-Tau217, in a cellular ‘Tau seeding’ system and in Tau[P301S] mice, followed by validation using a human 3D microfluidic system. At molecular level, αA is a robust mitochondrial regulator, enhancing mitochondrial stress resilience and activation of mitophagy. Mechanistically, αA inhibits dual leucine zipper kinase (DLK), leading to the inhibition of DLK-Sterile Alpha and TIR Motif Containing 1 (SARM1)-dependent neurodegeneration; this inhibition frees unc-51 Like Autophagy Activating Kinase 1 (ULK1) from the ULK1-SARM1 complex, allowing it to participate in autophagy/mitophagy. αA also shows strong translational potential with a 10.1 h half-life and the ability to cross the blood-brain barrier. Our results indicate that αA may act as a mitochondrial guardian against AD via modulating the DLK-SARM1-ULK1-autophagy/mitophagy axis while further preclinical and clinical studies are warranted, The authors confirm this project was funded by the Molecule AG/VITADAO (#282942), the Research Council of Norway (#262175 and #334361), HELSE SØR-ØST (#2020001, #2021021, and #2023093), NordForsk Foundation (#119986), the National Natural Science Foundation of China (#81971327), Akershus University Hospital (#269901, #261973, and #262960), the Civitan Norges Forskningsfond for Alzheimers sykdom (#281931), the Czech Republic-Norway KAPPA programme (with Martin Vyhnálek, #TO01000215), HORIZON-TMA- MSCA-DN (#101073251, with Riekelt Houtkooper), and Wellcome Leap’s Dynamic Resilience Program (jointly funded by Temasek Trust) (#104617). S.Q.C. is supported by Nasjonalforeningen for folkehelsen (#43622), the scholarships from the Graduate School, Chulalongkorn University to commemorate 72nd Anniversary of his Majesty King Bhumibol Adulyadej and the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship as well as the 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) and Overseas Research Experience scholarship for Graduate students. J. I. J.-L. is supported by an FPI fellowship from MCIN (PRE2019-088222). G.C. is supported by Guangdong Basic and Applied Basic Research Foundation (2022B1515120043). J.P.P is funded by the Natural Science Foundation of China (grant no. 82301422). K.P. is supported by grants from the Fondation Santé (19656) and the European Research Council (GA 101077374 – SynaptoMitophagy). N.T. is supported by the European Research Council, under the grant agreement ERC-GA695190-MANNA. H.C. and K.V.D are supported by the National Research Foundation (NRF-2020R1A2C2010285 and NRF-I21SS7606036), the Ministry of Health & Welfare and Ministry of Science and ICT (HU22C0115). R.M is funded by the Hellenic Fundation for Research and Innovation grant HFRI-1019 DiseasePhenoTarget. Y.J.K. is supported by NRF-2022R1I1A1A01063094. Q.H.Z. is supported by National Natural Science Foundation of China (# 82371429), D.D. is supported by the National Natural Science Foundation of China (#82473701 and #82173599). Research in P.B. lab is supported by grant PID2021-126864NB-I00 from MCIN, Spain, the University of of Fribourg and grant 310030-215271 from the SNSF, Switzerland., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Mamíferos - Roedores, in vitro - Tipos celulares - líneas estables humanas
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chaperone-mediated autophagy: the Achilles heel of the retinal pigment epithelium during age-related macular degeneration

  • Jiménez-Loygorri, Juan Ignacio
  • Cuervo, Ana Maria
  • Ferrington, Deborah A.
  • Boya, Patricia
Chaperone-mediated autophagy (CMA) is a selective autophagy pathway that targets specific proteins containing a KFERQ-like motif for lysosomal degradation. It has been shown by us and others that CMA decreases during physiological aging in most tissues, and its impairment is associated with increased incidence of age-related pathologies, such as cardiovascular disease, neurodegenerative disorders or sarcopenia. However, its involvement in age-related macular degeneration (AMD), a prevalent progressive maculopathy that leads to bilateral central vision loss, had not been explored. In the early stages of AMD, the retinal pigment epithelium (RPE), a monolayer of cells that provides trophic support to photoreceptors, already presents major morphological and functional alterations but the cause of this cell type-specific vulnerability is unknown. In our latest work, we analyzed human donor RPE samples and found that CMA is selectively impaired in the RPE of AMD patients compared to healthy donors. These alterations lead to the accumulation of undegraded CMA substrates and untimely recycling of other proteins. Crucially, these findings are conserved in donor-derived iPSC-RPE models. We used this clinically relevant model to assess the consequences of dysfunctional CMA in AMD and found that it caused proteotoxicity, increased oxidative damage, and altered metabolism. Most importantly, using the new-generation CMA activator CA77.1, we restored proteostasis in AMD iPSC-RPE. Our findings shed light on the selective vulnerability of the RPE in AMD and provide evidence in support of CMA as a novel druggable target against AMD, Research in the PB lab is supported by grants [310030_215271] from the Swiss National Science Foundation (SNSF) and [PID2021-126864NB-I00] from MCIN, Spain. JIJ-L is supported by an FPI predoctoral fellowship [PRE2019-088222] from MCIN, Spain and a CNIO Friends postdoctoral fellowship (Fundación Amigos del CNIO). Research in the DAF lab issupported by a grant from the National Institutes of Health/National Eye Institute [R01EY028554, U01EY034669] and the Stephen J. Ryan-Arnold and Mabel Beckman Foundation Endowed Presidential Chair. Research in the AMC lab is supported by grants from the National Institutes ofHealth/National Institute on Aging [AG021904, AG031782] and generous support of the Freedom Together (former JPB) Foundation and Hevolution Foundation, Peer reviewed, Sin experimentacion animal ni uso de NAMs